General Information
BounceWatch is an independent company data service, not affiliated with Tarsus Pharmaceuticals, Inc.. To contact Tarsus Pharmaceuticals, Inc., visit tarsusrx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Tarsus Pharmaceuticals, Inc. compare?
A PDF of Tarsus Pharmaceuticals, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Tarsus Pharmaceuticals, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biopharma
About Tarsus Pharmaceuticals, Inc.
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $75.00M | 2 |
Pharmakon Advisors, BioPharma Credit
|
19 Apr 2024 |
| Post IPO Equity | $100.00M | - |
|
29 Feb 2024 |
| Post IPO Equity | $100.00M | - |
|
01 Aug 2023 |
| Post IPO Equity | $75.60M | - |
|
03 May 2022 |
| Post IPO Debt | $175.00M | 1 | 01 Jan 2022 | |
| Series B | $60.00M | 6 | 08 Jan 2020 | |
| Series A | Undisclosed | - |
|
01 Mar 2018 |
Tarsus Pharmaceuticals, Inc. Alternatives & Competitors
View All AlternativesAdvancing the Standard of Care in Ophthalmics
Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-...
On a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin...
FAQ About Tarsus Pharmaceuticals, Inc.
Source: BounceWatch company record for Tarsus Pharmaceuticals, Inc., https://bouncewatch.com/company/tarsus-pharmaceuticals-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.